FundingWatcher
Home / Startups / By venture fund / National Institutes of Health portfolio companies

National Institutes of Health portfolio companies

Updated 16 Nov 2026

http://www.nih.gov

National Institutes of Health portfolio companies
One-time CSV
  • 32 funded companies, 32 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-national-institutes-of-health.csv32 rows × 18 columns
CompanyCityLast roundAmountDate
RamonaDurhamSeries A$25.0M2026-09-22
Talus BioSeattleSeed$11.2M2026-09-21
SamayMountain ViewSeed$350K2026-05-26
Glyphic BiotechnologiesNew YorkSeries A$38.0M2025-09-26
Terrestrial BioCambridgeSeries C$50.0M2026-03-26
EmulateBostonSeries F$47.1M2024-03-20
Curi BioSeattleSeries B$10.0M2025-12-02
Epicore BiosystemsCambridgeSeries B$6.0M2025-05-01

8 rows of the CSV in 5 of its 18 columns.

32
Startups
$1.4B
Total raised
5
Funded in the last 12 months
$96.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

21 of 32
21 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Ramona Ramona develops high-throughput microscopy tools for biology labs. Artificial intelligence Durham, United States Series A $25.0M 2026-09-22 $59.7M National Science Foundation, National Institutes of Health, E14 Fund +1 11 to 50 2017
Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle, United States Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
Samay Samay develops an AI patch platform for diagnosing and managing COPD. Artificial intelligence Mountain View, United States Seed $350K 2026-05-26 $5.2M National Institutes of Health, VentureWell 11 to 50 2019
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge, United States Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Seattle, United States Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015
South Rampart Pharma South Rampart Pharma develops pain medications designed to reduce the risks of current treatments. Biotech New Orleans, United States Series A $8.0M 2025-05-21 $8.0M National Institutes of Health 1 to 10 2017
Epicore Biosystems Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. Hardware Cambridge, United States Series B $6.0M 2025-05-01 $41.9M Alumni Ventures, National Institutes of Health, Joyance Partners +1 11 to 50 2017
Biomotum Biomotum builds wearable robotics for rehabilitation. Hardware Portland, United States Seed $290K 2025-03-03 $7.8M National Institutes of Health, Remarkable, Bend Venture Conference +2 1 to 10 2019
iotaMotion IotaMotion develops robotics-assisted solutions for cochlear implant surgery. Biotech Saint Paul, United States Series B $6.4M 2025-01-28 $31.3M National Science Foundation, National Institutes of Health, Next Level Ventures +2 11 to 50 2015
Springbok Analytics Springbok Analytics offers an AI platform that turns MRI scans into three-dimensional muscle analyses. Artificial intelligence Charlottesville, United States Series A $5.0M 2025-01-24 $11.2M Alumni Ventures, National Science Foundation, National Institutes of Health +1 11 to 50 2013
PhotoniCare PhotoniCare develops diagnostic medical devices to improve clinical outcomes and meet unmet patient needs. Health care Champaign, United States Series B $4.6M 2024-12-04 $22.8M National Science Foundation, Dreamit Ventures, MedTech Innovator +2 11 to 50 2013
NextStep Robotics NextStep Robotics develops a treatment for foot drop to help stroke survivors. Artificial intelligence Baltimore, United States Seed $200K 2024-11-13 $3.6M TEDCO, National Institutes of Health, University System of Maryland Momentum Fund +1 11 to 50 2017
Modality.AI Modality.AI provides self-driven neurological assessments. Artificial intelligence San Francisco, United States Seed $571K 2024-10-07 $7.1M Alchemist Accelerator, Creative Destruction Lab, National Institutes of Health +2 11 to 50 2018
ONL Therapeutics ONL Therapeutics develops biopharmaceuticals that protect photoreceptors to preserve vision. Biotech Ann Arbor, United States Series D $65.0M 2024-09-13 $147.9M National Institutes of Health, Johnson & Johnson Innovation, Biosciences Research and Commercialization Center (BRCC) 11 to 50 2011
VenoStent VenoStent develops bioabsorbable polymer wraps that improve outcomes in vascular surgery. Biotech Houston, United States Series A $4.0M 2024-06-27 $29.8M Y Combinator, Alumni Ventures, National Science Foundation +2 11 to 50 2017
Raydiant Oximetry Raydiant Oximetry makes medical devices that improve outcomes for mothers and babies during childbirth. Biotech San Ramon, United States Series A $7.5M 2024-06-04 $25.6M National Science Foundation, Enterprise Ireland, National Institutes of Health +1 11 to 50 2016
Emulate Emulate creates advanced in vitro models to study how diseases, medicines, and chemicals affect human health. Biotech Boston, United States Series F $47.1M 2024-03-20 $271.3M Alumni Ventures, Qiming Venture Partners, National Institutes of Health 51 to 100 2013
Cytonus Therapeutics Cytonus Therapeutics develops novel therapeutics using its proprietary drug delivery platform. Artificial intelligence Carlsbad, United States Series A $11.7M 2023-11-03 $20.9M National Institutes of Health, Creative Ventures 11 to 50 2018
HealthRhythms HealthRhythms builds a platform that assesses, monitors, and treats mental health conditions. Artificial intelligence Long Island City, United States Seed $11.0M 2022-02-02 $13.1M MassChallenge, City Light Capital, National Institutes of Health +2 11 to 50 2014
NovaSignal NovaSignal commercializes a robotic system for cerebral ultrasound imaging. Artificial intelligence Los Angeles, United States Series C $37.0M 2021-09-28 $127.9M MassChallenge, National Science Foundation, TCA Venture Group +2 51 to 100 2013
HeartVista HeartVista is a medical technology company that develops cardiac imaging software. Artificial intelligence Los Altos, United States Series A $8.7M 2020-04-28 $8.7M Khosla Ventures, National Institutes of Health, Open Field Capital 11 to 50 2012

Table 1. National Institutes of Health portfolio companies: the 21 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 32.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge, United States Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
2 Ramona Ramona develops high-throughput microscopy tools for biology labs. Artificial intelligence Durham, United States Series A $25.0M 2026-09-22 $59.7M National Science Foundation, National Institutes of Health, E14 Fund +1 11 to 50 2017
3 Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle, United States Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
4 Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Seattle, United States Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015
5 Samay Samay develops an AI patch platform for diagnosing and managing COPD. Artificial intelligence Mountain View, United States Seed $350K 2026-05-26 $5.2M National Institutes of Health, VentureWell 11 to 50 2019

Table 2. National Institutes of Health portfolio companies: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 National Science Foundation Entrepreneurship program Alexandria, United States 8 25% 2 Ramona, Talus Bio
2 Alumni Ventures Angel group Manchester, United States 6 19%
3 One North Carolina Small Business Program Government investment office Raleigh, United States 2 6% 1 Ramona
4 Y Combinator Startup accelerator Mountain View, United States 2 6% 1 Talus Bio
5 RA Capital Management Startup incubator Boston, United States 2 6% 1 Terrestrial Bio
6 MassChallenge Startup accelerator Boston, United States 2 6%
7 E14 Fund Micro VC fund Cambridge, United States 1 3% 1 Ramona
8 Pioneer Fund Startup accelerator Toronto, Canada 1 3% 1 Talus Bio
9 Fifty Years Micro VC fund San Francisco, United States 1 3% 1 Talus Bio
10 VentureWell Startup accelerator Hadley, United States 1 3% 1 Samay
11 stealthcap.com Venture capital firm New York, United States 1 3%
12 Civilization Ventures Venture capital firm San Francisco, United States 1 3%
13 Cantos Micro VC fund San Francisco, United States 1 3%
14 The Engine Venture capital firm Cambridge, United States 1 3% 1 Terrestrial Bio
15 Qiming Venture Partners Venture capital firm Shanghai, China 1 3%

Table 3. National Institutes of Health portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 31 97% $1.4B
Biotech 20 62% $1.3B
Software 17 53% $342.5M
Artificial intelligence 12 38% $319.4M
Hardware 8 25% $166.5M
Education 1 3% $500K

Table 4. National Institutes of Health portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 1 3%
Seed 10 31% $571K
Series A 9 28% $8.7M
Series B 5 16% $6.4M
Series C 3 9% $50.0M
Series D+ 4 12% $48.0M

Table 5. National Institutes of Health portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
New York 3 9%
Seattle 2 6%
Cambridge 2 6%
Boston 2 6%
Durham 1 3%
Mountain View 1 3%
San Diego 1 3%
Los Angeles 1 3%
Charlottesville 1 3%
Alameda 1 3%
Long Island City 1 3%
Charlestown 1 3%

Table 6. National Institutes of Health portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 2 40% $36.2M
May 2026 1 20% $350K
March 2026 1 20% $50.0M
December 2025 1 20% $10.0M

Table 7. National Institutes of Health portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 12% $86.5M
2025 7 22% $73.7M
2024 12 38% $176.9M
2023 3 9% $15.0M
2022 1 3% $11.0M
2021 2 6% $47.0M

Table 8. National Institutes of Health portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 4 12%
2015 to 2019 14 44%
2010 to 2014 12 38%
Before 2010 2 6%

Table 9. National Institutes of Health portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 6 19%
11 to 50 23 72%
51 to 100 2 6%
101 to 250 1 3%

Table 10. National Institutes of Health portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many National Institutes of Health portfolio companies are on the list?
32, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 32 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

National Institutes of Health portfolio companies: 32 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 32 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/national-institutes-of-health/